Hepatitis with Fibrin-Ring Granulomas
- 9 October 2007
- journal article
- case report
- Published by Springer Nature in Infection
- Vol. 36 (4) , 381-383
Abstract
We describe a 66-year-old woman hospitalized with fever, fatigue and hepatopathy. In her medical history arterial hypertension (treated with propranolol and lisinopril), diabetes mellitus type 2 (no treatment before admission) and a gout arthropathy were noted wherefore a therapy with allopurinol 300 mg per day has been started 4 months before. Liver biopsy revealed fibrin-ring granulomas, compatible with allopurinolinduced hepatitis. Because of persistence of high fever after stopping allopurinol, steroids (1 mg/kg) were started. Under this treatment, she developed pancytopenia and fever. The bone marrow aspiration revealed Leishmania infantum. A second liver biopsy showed amastigotes and a disappearance of the granulomas. The history revealed a travel to Malta 2 years earlier. Despite adequate treatment with liposomal amphotericin B the patient deteriorated and finally died in septic shock.Keywords
This publication has 15 references indexed in Scilit:
- Liver biopsy in the diagnosis of visceral leishmaniasisJournal of Gastroenterology and Hepatology, 2006
- Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniatePathogens and Global Health, 2005
- Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLPDiagnostic Microbiology and Infectious Disease, 2003
- THERAPY OF VISCERAL LEISHMANIASIS IN RENAL TRANSPLANT RECIPIENTS INTOLERANT TO PENTAVALENT ANTIMONIALSTransplantation, 2000
- Kala-AzarActa Cytologica, 1996
- Liver morphology and function in visceral leishmaniasis (Kala-azar).Journal of Clinical Pathology, 1994
- Hepatic fibrin-ring granulomas: A clinicopathologic study of 23 patientsHuman Pathology, 1991
- Fibrin ring granulomas and allopurinolGastroenterology, 1989
- Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future StrategiesClinical Infectious Diseases, 1988
- LEISHMANIA DONOVANI: AN OPPORTUNISTIC MICROBE ASSOCIATED WITH PROGRESSIVE DISEASE IN THREE IMMUNOCOMPROMISED PATIENTSThe Lancet, 1986